
Therapies for Retinal Degeneration
Targeting Common Processes
- 260 pages
- English
- PDF
- Available on iOS & Android
About this book
Sight loss and blindness is a very prevalent cause of disability. Retinal diseases leading to visual loss affect many people worldwide and the search for adequate drugs remains a challenge and an important area of interest in the drug discovery field. This book addresses approaches to the treatment of retinal diseases, targeting common processes and components. Despite their causative origins, which comprise genetic dystrophies, age-related degenerations, as well as pathologies associated with other diseases, a neurodegenerative component appears, sooner or later, in the course of the disease. As is the case for most neurodegenerative diseases, the available treatments are far from satisfactory. The aim of this book is to highlight research and drug development efforts in targeting such common processes as a potential path to provide treatments to the millions of affected people.
Frequently asked questions
- Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
- Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Information
Table of contents
- Cover
- Therapies for Retinal Degeneration: Targeting Common Processes
- Preface
- Contents
- Chapter 1 - The Cellular Course of Retinal Degenerative Conditions
- Chapter 2 - Immune Response of the Retina
- Chapter 3 - Modulation of Calcium Overload and Calpain Activity
- Chapter 4 - CNS Targets for the Treatment of Retinal Dystrophies: A Win–Win Strategy
- Chapter 5 - Modulation of p75NTR/Pro-NGF as a Therapeutic Approach for Degenerative Retinopathies
- Chapter 6 - Modulation of cGMP-signalling to Prevent Retinal Degeneration
- Chapter 7 - PEDF Peptides in Retinal Degenerations
- Chapter 8 - Beyond Anti-inflammation: Steroid-induced Neuroprotection in the Retina
- Chapter 9 - Alternative Experimental Models of Ciliary Trafficking and Dysfunction in the Retina
- Chapter 10 - Drug Delivery Systems for the Treatment of Diseases Affecting the Retina and Optic Nerve
- Chapter 11 - Gene Therapies for Retinal Degenerations
- Chapter 12 - Stem Cell Therapies for Retinal Repair and Regeneration
- Chapter 13 - The Application of Lipid Nanoparticles for Retinal Degenerative Diseases
- Chapter 14 - Biologicals in Retinal Therapy
- Subject Index